: Eli Lilly stock jumps 8% after Alzheimer’s treatment slows disease progression in major trial

May 3, 2023

Eli Lilly & Co.’s stock jumped 8% premarket Wednesday, after the company LLY announced positive results from a late-stage trial of its Alzheimer’s disease treatment donanemab.

The Phase 3 trial showed that donanemab “significantly slowed cognitive and functional decline” in patients with early symptomatic Alzheimer’s disease, and met its primary and all secondary endpoints, or goals.

Nearly…

Futurist Eric Fry says it will be a “Summer of Surge” for these three stocks

One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.

Watch now…